Taris Biomedical lands $25m Series B following Bristol-Myers deal

One day after announcing a research collab with Bristol-Myers Squibb (NYSE:BMY), Taris Biomedical revealed that it has raised $25 million in a Series B round.

Bristol-Myers also contributed to the round, which was led by Yonghua Capital.

Get the full story at our sister site, Drug Delivery Business News.

The post Taris Biomedical lands $25m Series B following Bristol-Myers deal appeared first on MassDevice.

from MassDevice http://ift.tt/2CQeyu4